Ann Clin Microbiol.
2018 Jun;21(2):45-45. 10.5145/ACM.2018.21.2.45.
Correction: Clinical Evaluation of QMAC-dRAST for Direct and Rapid Antimicrobial Susceptibility Test with Gram-Positive Cocci from Positive Blood Culture Bottles
- Affiliations
-
- 1QuantaMatrix Inc., Seoul National University Hospital, Seoul, Korea.
- 2Institutes of Entrepreneurial BioConvergence, Seoul National University, Seoul, Korea.
- 3Department of Electrical and Computer Engineering, Seoul National University, Seoul, Korea.
- 4Department of Transdisciplinary Studies, Seoul National University, Seoul, Korea.
- 5Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Korea.
- 6Seoul National University Hospital Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.
- KMID: 2414139
- DOI: http://doi.org/10.5145/ACM.2018.21.2.45
Abstract
- There was an error in the article, the names of manufacturers and countries of equipments in the Korean abstract were reversed.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Clinical Evaluation of QMAC-dRAST for Direct and Rapid Antimicrobial Susceptibility Test with Gram-Positive Cocci from Positive Blood Culture Bottles
- Performance Evaluation of QMAC-dRAST Using Consecutive Positive Clinical Blood Culture Samples
- Clinical Usefulness of the QMAC-dRAST System for AmpC β-lactamase-Producing Enterobacterales
- Evaluation of MicroScan and Phoenix System for Rapid Identification and Susceptibility Testing Using Direct Inoculation from Positive BACTEC Blood Culture Bottles
- A Direct Rapid Phenotypic Antimicrobial Susceptibility Test Enables Early Selection of Optimal Antibiotics to Treat Bacteremia in COVID-19 Patients
